COMMUNIQUÉS West-GlobeNewswire

Optum and Syneos Health Partner to Advance an Adaptive Clinical Development Model
20/10/2026
Partnership Will Transform How Clinical Development is Designed and Executed MORRISVILLE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Syneos Health® today announced a partnership with Optum to build a more adaptive and [...]
Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress
20/10/2026
The oral presentation will share results from a 12-week comparative study showing that Omada GLP-1 Care Track members, on average, lost more weight and saw greater improvements in body composition than controls SAN [...]
Applied Biologics Announces Acceptance for Publication of Interim Results from Randomized Controlled CAMPX Trial Evaluating XWRAP®
20/10/2026
Peer-reviewed interim clinical data demonstrated higher wound closure rates and greater wound-area reduction with XWRAP plus standard of care compared with standard of care alone SCOTTSDALE, Ariz., Oct. 20, 2026 (GLOBE [...]
Aeroflow Health Survey Finds Nearly Half of Medicaid Members Are Unprepared for 2027 Work Requirements
20/10/2026
Eligible Medicaid members could lose coverage because of confusion about eligibility, exemptions and documentation, not because they failed to meet the new requirements ASHEVILLE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE [...]
Centivo Adds Two Industry Veterans to Leadership Team
20/10/2026
Longtime Health System Consultant Dr. Lisa Bielamowicz joins as Chief Health Officer Health Benefits Consultant and Sales Leader James Parr joins as Chief Commercial Officer BUFFALO, N.Y., Oct. 20, 2026 (GLOBE NEWSWIRE [...]
Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs
20/10/2026
First in a planned network of specialty pharmacy partnerships provides medication coordination and preferred pricing for OB/GYNs and their patients ATLANTA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY [...]
Inseer Appoints Eugene “Woody” Ritchey CEO to Lead Next Phase of Enterprise Growth
20/10/2026
Company introduces Enterprise Human Motion Intelligence strategy, expanding on its AI-powered human motion analysis to improve workplace safety, productivity and performance IOWA CITY, Iowa, Oct. 20, 2026 (GLOBE [...]
Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
20/10/2026
International Scientific Presentation Underscores Encouraging Clinical Outcomes and Additional Biological Potency Findings Supporting Cell-Free Regenerative Platform PHOENIX, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Creative [...]
MRI Patients Want to Keep Their Respirators On. ReadiMask Gives Technologists Independent MR Safe Documentation
20/10/2026
MED Institute's ASTM F2503-26 determination supports a strapless, adhesive-sealing respirator for MRI use, addressing an important safety question for patients and imaging professionals ReadiMask® worn by a patient [...]
Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season
20/10/2026
NeOnc’s November FDA Meeting and Abu Dhabi Treatment Developments Put Brain Cancer Research in the Spotlight DENVER, Oct. 20, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- At an ugly-sweater party, the one with the [...]
Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer
20/10/2026
Study launched earlier this year is expected to confirm previous efficacy signal in 2L KRAS-mutant MSS colorectal cancer study that saw 17 months PFS vs. 6 months for the historical standard of care SAN DIEGO, Oct. 20, [...]
Five Years After Netflix’s ‘Sex, Love & Goop,’ Darshana Avila Announces ‘It’s My Pleasure’ Women’s Retreat
20/10/2026
The sexological bodyworker featured on the series says the conversation about women's sexual health has opened up since 2021, even as social media keeps shutting it down. Oakland, CA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- [...]
As Autism and ADHD Diagnoses Surge, Love on the Autism Spectrum Offers Free Sessions for Long-Married Couples Who Never Had a Name for It
20/10/2026
Late-identified at 57 and with her partner more than 40 years, couples specialist Barbara "Blaze" Lazarony says the crisis isn't the diagnosis. It's the decades of marriage spent without one. Pacific Grove, CA, Oct. 20 [...]
Applied AI Company Baba Raises $40 Million Series A to Improve the Medicare Experience
20/10/2026
Round led by FirstMark Capital, with CVS Health Ventures and Valtruis joining returning investors General Catalyst, Genius Ventures and Ground Up Ventures Funding will expand Baba’s clinical care teams, advance its AI [...]
MyCardiologist Opens New Ambulatory Care Center in Miami Lakes, Expanding Access to Outpatient Cardiovascular Care
20/10/2026
MyCardiologist Ambulatory Care Center provides specialized cardiovascular procedures in an outpatient setting and strengthens MyCardiologist’s ability to care for patients throughout South Florida MIAMI LAKES, Fla., Oct [...]
ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026
20/10/2026
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETs Separate independent, investigator-led [...]
Correction: ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026
20/10/2026
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETs Separate independent, investigator-led [...]
Slate Medicines Strengthens Board of Directors with Appointment of Stephen K. Brannan, MD, and John D. Young
20/10/2026
RALEIGH, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Slate Medicines, Inc. (“Slate”), a clinical-stage biotechnology company committed to advancing innovative new therapies that may broaden the treatment paradigm and [...]
Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026
20/10/2026
Correlation between clinical efficacy and changes in inflammatory biomarkers, mucosal transcriptomic signatures, and histologic disease activity strengthens the previously shown clinical proof of concept for OD-001 [...]

Pages